<TABLE> <S> <C>

<ARTICLE> 5
<CIK> 0001030418
<NAME> BIONX IMPLANTS, INC.
<MULTIPLIER> 1000
<CURRENCY> US DOLLARS

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<EXCHANGE-RATE>                                      1
<CASH>                                           6,926
<SECURITIES>                                         0
<RECEIVABLES>                                    2,647
<ALLOWANCES>                                       387
<INVENTORY>                                      7,661
<CURRENT-ASSETS>                                18,854
<PP&E>                                           2,397
<DEPRECIATION>                                     301
<TOTAL-ASSETS>                                  25,257
<CURRENT-LIABILITIES>                            3,901
<BONDS>                                              0
                                0
                                          0
<COMMON>                                            21
<OTHER-SE>                                      20,855
<TOTAL-LIABILITY-AND-EQUITY>                    25,257
<SALES>                                          9,368
<TOTAL-REVENUES>                                 9,542
<CGS>                                            3,411
<TOTAL-COSTS>                                   10,811
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 109
<INCOME-PRETAX>                                (1,160)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (1,160)
<EPS-BASIC>                                     (0.11)
<EPS-DILUTED>                                   (0.11)


</TABLE>



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission